PIK3CA and breast carcinoma: The PIK3CA gene is one of the most frequently mutated genes in breast cancer (Mukohara, 2015), which leads to PI3K activation and serves as a key determinant of standard anticancer therapy resistance (Liu, et al., 2019; Luo, et al., 2018; Qiu, et al., 2019).